Provention Bio: Funding, Investors & Team (Sep 2026)
A clinical-stage biopharmaceutical business called Provention Bio is committed to finding, creating, and commercialising innovative medicines and cutting-edge treatments to detect and stop immune-mediated disease. Its "predict and prevent" concept focuses on creating cutting-edge therapy strategies that act early on to intervene before the target disease starts, reappears, or worsens. With the potential to lessen the high morbidity, mortality, patient suffering, and rising costs of chronic autoimmune and inflammatory diseases like type 1 diabetes (T1D), Crohn's disease, ulcerative colitis, and emerging viral infections, Provention Bio is well-positioned to become a leader in this new biopharmaceutical category focused on the interception of disease. Provention Bio was meticulously designed, established, and placed to be at the forefront of this innovative new medical paradigm.
Provention Bio has raised $95.0M across 2 funding rounds on record, the most recent an undisclosed round of $35.0M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Provention Bio Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Provention Bio Funding Rounds
Provention Bio raised $60.0M in a Post-IPO Equity announced in Jul 2022.
7 months later, an undisclosed round of $35.0M was announced in Feb 2023.
Provention Bio Founders and Leadership Team
Contact details for the Provention Bio team: 1 of 2 have an email address on file.
Start 14-day free trial →Provention Bio Funding Compared to Other Biotechnology Startups
Provention Bio's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Provention Bio in Biotechnology and Red Bank
Companies Similar to Provention Bio
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Provention Bio Funding FAQs
What does Provention Bio do?
A clinical-stage biopharmaceutical business called Provention Bio is committed to finding, creating, and commercialising innovative medicines and cutting-edge treatments to detect and stop immune-mediated disease. Its "predict and prevent" concept focuses on creating cutting-edge therapy strategies that act early on to intervene before the target disease starts, reappears, or worsens. With the potential to lessen the high morbidity, mortality, patient suffering, and rising costs of chronic autoimmune and inflammatory diseases like type 1 diabetes (T1D), Crohn's disease, ulcerative colitis, and emerging viral infections, Provention Bio is well-positioned to become a leader in this new biopharmaceutical category focused on the interception of disease. Provention Bio was meticulously designed, established, and placed to be at the forefront of this innovative new medical paradigm.
How much funding has Provention Bio raised?
Provention Bio has raised $95.0M across 2 rounds on record. The most recent is an undisclosed round of $35.0M announced in Feb 2023.
When did Provention Bio last raise funding?
Provention Bio's most recent funding round on record is an undisclosed round of $35.0M, announced in Feb 2023.
Who founded Provention Bio?
FundedIQ lists Francisco Leon (Founder) at Provention Bio.
Who is the CEO of Provention Bio?
Ashleigh Palmer is listed as CEO at Provention Bio.
Where is Provention Bio headquartered?
Provention Bio is based in Red Bank, New Jersey, United States.
How many employees does Provention Bio have?
Provention Bio is in the 101-250 employee band.
How does Provention Bio's funding compare to other Biotechnology startups?
Provention Bio's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Provention Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Provention Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.